Skip to main content
logo
China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.670
+0.050 (1.08%)
May 29, 2026, 4:08 PM HKT

HKG:3320 Revenue

In the year 2025, China Resources Pharmaceutical Group had annual revenue of 269.57B CNY with 4.62% growth. China Resources Pharmaceutical Group had revenue of 137.71B in the half year ending December 31, 2025, with 12.98% growth.

Revenue
269.57B CNY
Revenue Growth
+4.62%
P/S Ratio
0.10
Revenue / Employee
3.15M CNY
Employees
85,600
Market Cap
29.34B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025269.57B11.90B4.62%
Dec 31, 2024257.67B12.97B5.30%
Dec 31, 2023244.70B26.52B12.16%
Dec 31, 2022218.18B25.26B13.10%
Dec 31, 2021192.92B24.16B14.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
The United Laboratories International Holdings14.70B
Grand Pharmaceutical Group12.28B
Shandong Xinhua Pharmaceutical Company9.94B
China Medical System Holdings9.14B
Simcere Pharmaceutical Group8.60B
Sunshine Lake Pharma5.36B
Consun Pharmaceutical Group3.80B
Sihuan Pharmaceutical Holdings Group2.91B
Revenue Rankings

China Resources Pharmaceutical Group News

More News